Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005391592 | SCV006050196 | uncertain significance | not specified | 2024-12-23 | criteria provided, single submitter | clinical testing | The c.404A>G (p.E135G) alteration is located in exon 1 (coding exon 1) of the PDHA2 gene. This alteration results from a A to G substitution at nucleotide position 404, causing the glutamic acid (E) at amino acid position 135 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |